EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.
| Market Capitalization | $26.6906 million |
| P/E Ratio | 10.7 |
| P/E Growth Ratio | |
| Book Value | 0.342 |
| Dividend Per Share | 0 |
| Earnings Per Share | 0.06 |
| EBITDA | 5,093.04 |
| Profit Margin | 0.0969 |
| Operating Margin TTM | 0.1312 |
| Return on Assets TTM | 0.1924 |
| Return on Equity TTM | 0.2795 |
| Revenue TTM | 37,439.024 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2018-12-31 | 11,187.45 | 6,764.66 | 4,422.79 | |
| 2019-12-31 | 17,991.1 | 13,288.34 | 4,702.76 | |
| 2020-12-31 | 22,287.078 | 9,828.267 | 12,458.811 | 9,885.891 |
| 2021-12-31 | 15,022.026 | 7,513.521 | 7,508.505 | 5,866.105 |
| 2022-12-31 | 37,143.33 | 8,613.17 | 28,530.16 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2017-12-31 | 0.1 | 0.1 | 0 | 0 | 0.1 | |
| 2018-12-31 | 413.89 | 2,914.61 | 2,090.7 | 0 | 0.1 | |
| 2019-12-31 | 8,407 | 11,629 | 3,776 | 32 | 5,618 | |
| 2020-12-31 | 8,853.644 | 12,038.672 | 1,930.906 | 79.012 | 5,667.219 | |
| 2021-12-31 | 10,464.841 | 14,265.397 | 2,877.938 | 104.571 | 5,823.494 | |
| 2022-12-31 | 13,830.75 | 17,640.62 | 3,058.48 | 5,998.57 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2018-12-31 | 823.81 | 416.329 | 413.786 | 173.167 | ||
| 2019-12-31 | 1,586.131 | 2,974.385 | 2,760.94 | 3,174.826 | 173.167 | |
| 2020-12-31 | 2,030.606 | 253.533 | 5,678.818 | 3,174.826 | 8,853.644 | 173.167 |
| 2021-12-31 | 1,312.418 | 1,901.73 | 1,611.197 | 8,853.644 | 10,464.841 | 173.167 |
| 2022-12-31 | 3,629.727 | 4,014.26 | 3,365.91 | 10,464.841 | 13,830.751 | 600.39 |